| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: BHTX |
| Security Type |
Common Stock |
| Lead Underwriter |
Pacific Growth Equities Inc Lazard Capital Markets |
| Days In Registration |
170 |
| Date Filed |
9-Jan-2008 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Bayhill Therapeutics, located in Palo Alto, California, is a clinical-stage biopharmaceutical company using our proprietary therapeutic platform to develop a pipeline of novel products to treat autoimmune diseases in a fundamentally new manner. The company was formed under the name SunVax, Inc. and incorporated in Delaware in December 2000. The company subsequently changed its name to Tolerion, Inc. in April 2002 and to Bayhill Therapeutics, Inc. in November 2002. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
39 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
